Literature DB >> 33394707

Skeletal muscle (dys)function in heart failure with preserved ejection fraction.

Eng Leng Saw1, Swetha Ramachandran2, Maria Valero-Muñoz1, Flora Sam1,2.   

Abstract

PURPOSE OF REVIEW: Skeletal muscle dysfunction contributes to exercise intolerance, which manifests as dyspnea and fatiguability in patients with heart failure with preserved ejection fraction (HFpEF). This review aims to summarize the current understanding of skeletal muscle dysfunction in HFpEF. RECENT
FINDINGS: Animal and human studies in HFpEF provide insights into the pathophysiological alterations in skeletal muscle structure and function with the identification of several molecular mechanisms. Exercise training and novel pharmacological therapies that target skeletal muscle are proposed as therapeutic interventions to treat HFpEF.
SUMMARY: There is evidence that skeletal muscle dysfunction plays a pathophysiological role in HFpEF. However, precise mechanistic insights are needed to understand the contribution of skeletal muscle dysfunction in HFpEF.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33394707      PMCID: PMC7895420          DOI: 10.1097/HCO.0000000000000824

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.108


  66 in total

1.  Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure.

Authors:  Kilian Weiss; Michael Schär; Gurusher S Panjrath; Yi Zhang; Kavita Sharma; Paul A Bottomley; Asieh Golozar; Angela Steinberg; Gary Gerstenblith; Stuart D Russell; Robert G Weiss
Journal:  Circ Heart Fail       Date:  2017-07       Impact factor: 8.790

2.  Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction.

Authors:  Mark J Haykowsky; Erik J Kouba; Peter H Brubaker; Barbara J Nicklas; Joel Eggebeen; Dalane W Kitzman
Journal:  Am J Cardiol       Date:  2014-01-15       Impact factor: 2.778

3.  Skeletal Muscle Alterations Are Exacerbated in Heart Failure With Reduced Compared With Preserved Ejection Fraction: Mediated by Circulating Cytokines?

Authors:  Martin Seiler; T Scott Bowen; Natale Rolim; Maja-Theresa Dieterlen; Sarah Werner; Tomoya Hoshi; Tina Fischer; Norman Mangner; Axel Linke; Gerhard Schuler; Martin Halle; Ulrik Wisloff; Volker Adams
Journal:  Circ Heart Fail       Date:  2016-09       Impact factor: 8.790

Review 4.  Heart Failure With Preserved Ejection Fraction In Perspective.

Authors:  Marc A Pfeffer; Amil M Shah; Barry A Borlaug
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

Review 5.  Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology.

Authors:  Ravikumar Manickam; Walter Wahli
Journal:  Biochimie       Date:  2016-12-02       Impact factor: 4.079

6.  The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle.

Authors:  Jessica Chinsomboon; Jorge Ruas; Rana K Gupta; Robyn Thom; Jonathan Shoag; Glenn C Rowe; Naoki Sawada; Srilatha Raghuram; Zoltan Arany
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

7.  Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction.

Authors:  Dalane W Kitzman; Barbara Nicklas; William E Kraus; Mary F Lyles; Joel Eggebeen; Timothy M Morgan; Mark Haykowsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-21       Impact factor: 4.733

8.  Impaired skeletal muscle vasodilation during exercise in heart failure with preserved ejection fraction.

Authors:  Joshua F Lee; Zachary Barrett-O'Keefe; Ashley D Nelson; Ryan S Garten; John J Ryan; Jose N Nativi-Nicolau; Russell S Richardson; D Walter Wray
Journal:  Int J Cardiol       Date:  2016-03-02       Impact factor: 4.164

9.  A simple sarcopenia screening test predicts future adverse events in patients with heart failure.

Authors:  Yoshiro Onoue; Yasuhiro Izumiya; Shinsuke Hanatani; Tomoko Tanaka; Satoru Yamamura; Yuichi Kimura; Satoshi Araki; Kenji Sakamoto; Kenichi Tsujita; Eiichiro Yamamoto; Megumi Yamamuro; Sunao Kojima; Koichi Kaikita; Seiji Hokimoto
Journal:  Int J Cardiol       Date:  2016-04-17       Impact factor: 4.164

10.  Regulation of muscle fiber type and running endurance by PPARdelta.

Authors:  Yong-Xu Wang; Chun-Li Zhang; Ruth T Yu; Helen K Cho; Michael C Nelson; Corinne R Bayuga-Ocampo; Jungyeob Ham; Heonjoong Kang; Ronald M Evans
Journal:  PLoS Biol       Date:  2004-08-24       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.